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I. PROJECT REPORT 
General  
A transparent plexiglass model was designed to simulate the 
left ventricle of the heart. Its shape was based on 
echocardiographic observations performed at the onset of 
systole in human patients. Moderate or severe hypertrophy of 
the septum could also be simulated. An explanted native human 
valve with an intact papillary muscle apparatus was used in 
the model. The papillary muscles could be set to nearly any 
position inside the ventricle. Furthermore, the tension 
exerted on the two papillary muscles could be adjusted with , 
 stepper motors and recorded using load cells. The papillary 
muscles are attached to metal rods using small polycarbonate 
disks. The rods are themselves connected to stepper motors 
that can move a maximum of 600 steps / sec; each step 
represents 1/1000 inch. 
Two flow loops were developed. A steady flow loop was used to 
simulate a specific period of the cardiac cycle while a 
pulsatile one simulated the entire cardiac cycle. The 
pulsatile flow system duplicated the flow curves through the 
aortic and the mitral valves and the pressure waveforms in the 
ventricle, the atrium and the aorta. The system also 
reproduced atrial systole. 
These models have been used for two separate projects: 
Hypertrophic Cardiomyopathy 
Obstructive hypertrophic cardiomyopathy is a common heart 
disease which is characterized by systolic anterior motion 
(SAM) of the mitral valve. Until recently, the most common 
explanation for SAM was the Venturi mechanism which was based 
on high velocities created by the narrowed outflow tract 
associated with septal hypertrophy. This Venturi hypothesis, 
however, failed to explain how SAM can begin when the outflow 
tract velocities are low or negligible, a common clinical 
observation. The goal of this study was therefore to 
investigate a new hypothesis which stresses structural 
abnormalities of the papillary muscles as a primary cause for 
SAM. 
The beginning of systole, the moment at which SAM starts, was 
simulated with steady flow experiments using flow rates of up 
to 30 1/min (corresponding to a cardiac output of 5 1/min). 
The behavior of the mitral valve in a normal or SAM 
configuration was also observed throughout the cardiac cycle 
with the pulsatile flow system, over a cardiac output range of 
2 to 8 1/min. 
In order to observe the mitral valve configuration and the 
shape of the ventricular flow field, a 1 mm thick plane of. 
light was created in the center of the flow chamber, parallel 
to the long axis of the ventricle. Neutrally buoyant particles 
were added to the blood analog solution. Their motion closely 
approximated that of the fluid. As the particles passed 
through the laser plane, they refracted the light and 
displayed pathlines. Thus, this flow visualization technique 
allowed us to obtain two-dimensional qualitative maps of the 
left ventricular flow field. 
In the simulation of a normal heart (papillary muscles in 
apical, posterior and out position), the mitral valve had a 
flat anterior leaflet with most of the flow (the outflow 
tract) passing above it. The streamlines were smooth and 
followed the shape of the anterior leaflet, going toward the 
aorta. Then, by displacing the papillary muscles anteriorly 
and inward, the valve was moved into the outflow tract and SAM 
was initiated even for low flow rates. When SAM was present, 
streamlines could be seen impacting the proximal side of the 
leaflets, causing a drag force which maintained the mitral 
leaflets in anterior position. 
By simulating severe septal hypertrophy, it was possible to 
achieve velocities as high as 3.5 m/s above the mitral valve. 
However, as long as the papillary muscles were in normal 
position (posterior, outward), the mitral valve remained 
outside of the outflow tract and SAM could not be produced. 
Displacing the papillary muscles to a more inward and anterior 
position not only created SAM but also modified dramatically 
the ventricular flow field. Indeed, the mitral leaflets 
contacted the hypertrophied septum, obstructing the outflow 
tract and causing the fluid to recirculate inside the 
ventricle. In order to exit the ventricle, the flow now had to 
pass on the sides of the obstruction! 
Therefore, these experiments have shown that high velocities 
above the mitral valve cannot initiate SAM alone, even when 
the septum is hypertrophied. At the same time, without septal 
hypertrophy, SAM was initiated even at low flow rates by 
displacing the papillary muscles to a more anterior (valve 
moved in the outflow tract) and inward (tension distribution 
within the leaflets altered and slackness in the center part 
of the valve, allowing it to move) position. Finally, the 
combination of papillary muscle displacement and septal 
geometry modified extensively the ventricular flow field. 
Thus, it seems that the papillary muscle displacement theory 
surpasses the Venturi mechanism to describe and explain SAM. 
Papillary Muscle Tension 
In pulsatile flow, software written in Turbo Pascal was 
developed for data acquisition in the pulsatile system. With 
this software, data was acquired in volts from five channels 
representing two papillary muscle tensions, aortic and mitral 
flow rates, and ventricular pressure - using an overall 
acquisition rate of 500 Hz. The data could be collected with 
or without the use of papillary muscle tension control. The 
acquisition of data was initiated using an external trigger 
from the pulse duplicator box used to produce pulsatile flow. 
A delay could also be placed between the trigger and the start 
of the data acquisition to compensate for the time between the 
electronic trigger and the actual start of mechanical events. 
After ten cycles were acquired, they were averaged together 
and the five average wave forms were displayed on the screen. 
The means and standard deviations per channel over all ten 
cycles were computed and displayed. The option to acquire ten 
more cycles was provided. If other cycles were being 
acquired, the trigger delay could be changed, and the motors, 
could be used to adjust the papillary muscle position. The 
program could then be reset for controlled or uncontrolled 
mode. When running the program in the controlled mode, the 
actual and desired tensions are compared at 10 msec intervals. 
The desired tension curve is calculated based on the pressure 
and stroke volume of ten cycles acquired without control. The 
papillary muscles could be moved a maximum of four steps 
during one of these intervals. The number of steps to move is 
calculated from a preset movement sequence combined with 
proportional integral control using the current error between 
the desired and actual tensions and the sum of errors. If a 
trigger delay is entered, instead of waiting to acquire data 
as in the uncontrolled mode, the desired tension curve and the 
preset movement sequence are shifted forward. This allows the 
papillary muscles to be moved during this delay period in 
order to help build up the tension. After acquiring ten 
cycles, along with the data displayed in the uncontrolled 
mode, the error, sum of errors, and motor movement curves are 
also displayed. The two papillary muscle tension curves are 
averaged together, filtered and displayed along with the 
desired tension curve. The motor movement curve can also be 
stored in a file. An opportunity to adjust the preset 
movement sequence is also provided at this time. 
The effects of left ventricular pressure and cardiac output on 
papillary muscle tension were investigated independently. The 
papillary muscles were held stationary in the normal position: 
low, out, and apical. Two types of mitral annulus rings were 
used: circular and elliptical. To determine the effect of the 
left ventricular pressure on papillary muscle tension, the 
peak ventricular pressure was varied from 80 to 160 mm Hg, at 
a constant cardiac output. Several cardiac outputs were used 
ranging from 4 to 8 1/min. Then, to determine the influence 
of the cardiac output on papillary muscle tension, the cardiac 
output was varied from 1 to 12 1/min at constant peak 
ventricular pressures ranging from 90 to 130 mm Hg. 
At constant cardiac output, the papillary muscle force 
increased linearly with the left ventricular pressure 
(r=0.99). Cardiac outputs below 6 1/min had almost no effect 
on the papillary muscle force. Above 6 1/min, the tension 
increased with the square of the flow rate (r=0.81), up to 25% 
compared to low cardiac outputs. These results were observed 
for both mitral annulus rings. 
Moreover, the papillary muscle tension was found to be greater 
with the elliptical mitral annulus. This result could be 
explained by Laplace's law stating that the mitral annulus 
tension equals the radius of curvature of the leaflet 
multiplied by the pressure gradient across the leaflet. 
Consequently, left ventricular pressure as well as cardiac 
output exert a large influence on the papillary muscle 
tension. The geometry of the mitral annulus (shape) is also' 
of great importance. 
Controlled pulsatile flow experiments were also conducted. 
The purpose of these experiments was to simulate the 
physiologic contraction of the papillary muscles by matching 
the papillary muscle tension to in vivo data published by 
Salisbury et al. The number of steps to move the motors each 
period of time (10 msec) was calculated from a preset movement 
sequence combined with proportional integral control based on 
the error at that step and the sum of errors. Experiments 
were performed to determine the best preset movement sequence 
by setting the control constants to zero. Experiments were 
also performed to find the best values of the control 
constants using a preset movement sequence of zero. Finally, 
the best preset sequence was combined with control. 
Results showed that the best matching between the two curves 
occurred for values of K. (proportional control constant) and 
Ki (integral contral constant) such that 0.01 < Hp < 0.02 and 
0.001 < Ki < 0.02. Also, the matching of the two curves 
depended on the position of the mitral valve. When the valve 
was in the low, in, apical position, the matching was better 
than in the normal position case. 
Finally, these two separate projects will eventually merge 
together. The forces exerted on the papillary muscles at the 
onset of SAM will be calculated using the same load cells. 
This would provide us more detailed fundamental information 
concerning the mechanism of this common disease. 
Lay Summary 
Because of the complex structure of the human mitral 
valve, it is especially susceptible to disease. A scientific 
understanding of its intricate workings is not currently 
available. Therefore, a long term study was undertaken in 
which an intact mitral valve apparatus could be mounted in a 
model of the left ventricle for engineering studies. A 
computer control system was first developed to control muscle 
movement as it would occur in the human body. After doing 
this, the patterns of muscle force were studied. Having 
established physiologic muscle character, the mechanism for 
systolic anterior motion of the mitral valve in hypertrophic 
cardiomyopathy was studied. The independent and accurate 
control of all normal and disease variables in our model 
allowed two competing hypotheses to be tested. The newest 
hypothesis, which was confirmed in this study over the 
existing Venturi theory, may lead to more simple surgical 
techniques to correct this common problem. 
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IV. RESEARCH CONTINUATION 
a. This project is being actively continued. 
b. Funding has been obtained from Medtronic, Inc. for 
$25,000 per year for two years. We have also received 
super-computer time from Cray, Inc. valued at about 
$250,000 for the next year, to conduct computer 
simulation studies on the systolic anterior motion of the 
mitral valve. 
A grant to NIH is being planned and is to be submitted in 
January 1991. 
